PIB News
Government Expands Price Controls on Cancer Medicines, Saving Patients ₹2,500 Crore Annually
The Indian government has approved new price controls on non-scheduled anti-cancer drugs, limiting profit margins to 30% of the Maximum Retail Price. This decision is expected to reduce medicine prices by up to 70%, allowing cancer patients to save ₹2,500 crore annually. The initiative aims to alleviate the financial burden on patients, as cancer treatment costs have been rising significantly. An expert committee will determine which medicines will be included in this price protection scheme, with further actions to be taken by the National Pharmaceutical Pricing Authority.
The Radius summarizes this story. Read the original report from PIB News.
Read Full